KTB
Kontoor Brands, Inc.
KTB has the edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
KTB Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Strong | |
| Stable |
KTB's profitability and cash flow are currently healthy, and its balance sheet is stable, but its revenue is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
KTB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $40.20 | -48% |
| Fair | 16x | $57.23 | -26% |
| Expensive | 20x | $72.73 | -6.5% |
| Current | 22x | $77.76 | — |
Historical ranges are pointers, not guarantees.
KTB's PE is in its expensive range at 22x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
KTB Forward outlook
There aren't enough analyst estimates for KTB to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
KTB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.59 | -7.2% |
| Q2 2026 | $4.79 | +7.2% |
| Q1 2026 | $4.94 | +21% |
| Q4 2025 | $4.05 | -7.1% |
| Q3 2025 | $3.87 | -13% |
| Q2 2025 | $4.47 | +5.7% |
| Q1 2025 | $4.07 | +3% |
| Q4 2024 | $4.36 | +7.4% |
KTB has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
KTB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $685.3M | -20% |
| Q2 2026 | $584.3M | -11% |
| Q1 2026 | $613.3M | -1.5% |
| Q4 2025 | $1B | +46% |
| Q3 2025 | $853.2M | +27% |
| Q2 2025 | $658.3M | +8.5% |
| Q1 2025 | $622.9M | -1.3% |
| Q4 2024 | $699.3M | +4.4% |
KTB's revenue has held roughly level: $685M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.8 points |
| Q2 2026 | 15% | +3.6 points |
| Q1 2026 | 15% | +2.9 points |
| Q4 2025 | 12% | -0.2 points |
| Q3 2025 | 7.5% | -7.2 points |
| Q2 2025 | 12% | -0.5 points |
| Q1 2025 | 12% | -1.6 points |
| Q4 2024 | 12% | +0.8 points |
KTB has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over KTB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
KTB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.3M | -15% |
| Q2 2026 | $45.4M | +103% |
| Q1 2026 | $40.3M | -46% |
| Q4 2025 | $281.8M | +276% |
| Q3 2025 | $55.8M | -57% |
| Q2 2025 | $22.4M | -76% |
| Q1 2025 | $74.9M | +44% |
| Q4 2024 | $75M | -63% |
KTB has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
KTB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 1.0x | Healthy |
| Q4 2024 | 1.1x | Healthy |
KTB's net debt is about 2.5 years of its operating earnings (EBITDA), down from 3.6 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KTB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.6 | Neutral |
| Stochastic | 56.5 | Neutral |
KTB's weekly RSI is 55 (neutral) and its Stochastic is 57 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
KTB PE vs Consumer Cyclical Sector
| Metric | KTB | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 85 | 47 | 38 pts above |
KTB is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
KTB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $71.8 | 8.4% above |
| 20 week MA | $76.3 | 2% above |
| 50 week MA | $71.9 | 8.2% above |
| 100 week MA | $72.5 | 7.3% above |
| 200 week MA | $65.4 | 19% above |
KTB has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
KTB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.5 | $41.5 | -2.3% |
| 2021 | $41.5 | $50.9 | +23% |
| 2022 | $50.9 | $39.6 | -22% |
| 2023 | $39.6 | $62.4 | +58% |
| 2024 | $62.4 | $85.2 | +36% |
| 2025 | $85.2 | $62.9 | -26% |
| 2026 YTD | $62.9 | $77.8 | +24% |
KTB has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.